These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18619228)

  • 1. Reticuloendothelium malignancy: current role of imaging.
    Sebastian S; Lucey BC
    Cancer Treat Res; 2008; 143():455-68. PubMed ID: 18619228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of imaging for adrenal malignant involvement.
    Blake MA; Kalra MK
    Cancer Treat Res; 2008; 143():319-29. PubMed ID: 18619224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
    Chavdarova LI; Tzonevska AD; Piperkova EN
    Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT, MR, and PET/MR in Lymphoma and Melanoma.
    Schwenzer NF; Pfannenberg AC
    Semin Nucl Med; 2015 Jul; 45(4):322-31. PubMed ID: 26050659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and functional imaging of thymic and mediastinal involvement in lymphoproliferative disorders.
    Priola AM; Galetto G; Priola SM
    Clin Imaging; 2014; 38(6):771-84. PubMed ID: 24997534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging in oncology. Preface.
    Cancer Treat Res; 2008; 143():v. PubMed ID: 18619211
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.
    Herrmann K; Queiroz M; Huellner MW; de Galiza Barbosa F; Buck A; Schaefer N; Stolzman P; Veit-Haibach P
    BMC Cancer; 2015 Dec; 15():1002. PubMed ID: 26699124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging findings of skeletal muscle lymphoma.
    Surov A
    Clin Imaging; 2014; 38(5):594-8. PubMed ID: 24735681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT.
    van Ufford HM; Kwee TC; Beek FJ; van Leeuwen MS; Takahara T; Fijnheer R; Nievelstein RA; de Klerk JM
    AJR Am J Roentgenol; 2011 Mar; 196(3):662-9. PubMed ID: 21343511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
    Balbo-Mussetto A; Cirillo S; Bruna R; Gueli A; Saviolo C; Petracchini M; Fornari A; Lario CV; Gottardi D; De Crescenzo A; Tarella C
    Clin Radiol; 2016 Mar; 71(3):271-9. PubMed ID: 26749081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma.
    Okada M; Sato N; Ishii K; Matsumura K; Hosono M; Murakami T
    Radiographics; 2010; 30(4):939-57. PubMed ID: 20631361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric malignancies: synopsis of current imaging techniques.
    Servaes S; Epelman M; Pollock A; Shekdar K
    Cancer Treat Res; 2008; 143():469-91. PubMed ID: 18619229
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI.
    Grueneisen J; Sawicki LM; Schaarschmidt BM; Suntharalingam S; von der Ropp S; Wetter A; Ruhlmann V; Quick HH; Forsting M; Umutlu L
    PLoS One; 2016; 11(6):e0157880. PubMed ID: 27327617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of distant metastases of prostate cancer.
    Pesapane F; Czarniecki M; Suter MB; Turkbey B; Villeirs G
    Med Oncol; 2018 Sep; 35(11):148. PubMed ID: 30218382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of thoracic malignancies.
    Digumarthy SR; Aquino SL
    Cancer Treat Res; 2008; 143():121-44. PubMed ID: 18619216
    [No Abstract]   [Full Text] [Related]  

  • 18. Imaging the lymphatic system: possibilities and clinical applications.
    Clément O; Luciani A
    Eur Radiol; 2004 Aug; 14(8):1498-507. PubMed ID: 15007613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/MRI for the evaluation of patients with lymphoma: initial observations.
    Heacock L; Weissbrot J; Raad R; Campbell N; Friedman KP; Ponzo F; Chandarana H
    AJR Am J Roentgenol; 2015 Apr; 204(4):842-8. PubMed ID: 25794075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracranial head and neck neoplasms: role of imaging.
    Petrou M; Mukherji SK
    Cancer Treat Res; 2008; 143():93-117. PubMed ID: 18619215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.